A researcher is studying the effects of various substances on mature B-cells. She observes that while most substances are only able to promote the production of antibodies when the B-cells are co-cultured with T-cells, a small subset of substances are able to trigger antibody production even in the absence of T-cells. She decides to test these substances that stimulate B-cells alone by injecting them into model organisms. She then analyzes the characteristics of the response that is triggered by these substances. Which of the following correctly describes how the immune response triggered by the B-cell-alone-substances compares with that triggered by substances that also require T-cells?
AIs T-dependent
BIs T-independent
CRequires MHC class II presentation
DRequires cognate interaction
ERequires B7-CD28 interaction
A 33-year-old woman with a history of multiple sclerosis is brought to the physician because of dizziness, urinary incontinence, loss of vision in her right eye, and numbness and weakness of the left leg. She has had recurrent episodes of neurological symptoms despite several changes in her medication regimen. An MRI of the brain shows several new enhancing lesions in the periventricular white matter and the brainstem. Treatment with a drug that binds to CD52 is initiated. Which of the following agents was most likely prescribed?
AAlemtuzumab
BEculizumab
CAbciximab
DRituximab
EBevacizumab
A 61-year-old man presents to the emergency department with new-onset dizziness. He reports associated symptoms of confusion, headaches, and loss of coordination. The patient’s wife also mentions he has had recent frequent nosebleeds. Physical examination demonstrates a double vision. Routine blood work is significant for a slightly reduced platelet count. A noncontrast CT of the head is normal. A serum protein electrophoresis is performed and shows an elevated IgM spike. The consulting hematologist strongly suspects Waldenström’s macroglobulinemia. Which of the following is the best course of treatment for this patient?
APlasmapheresis
BVincristine
CCyclophosphamide
DRituximab
EPrednisone
+ 7 more in the PDF
Browse all chapters